Publications by authors named "Jessica Rusert"

Claim this Profile
D
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.
Anna Borgenvik, Karl O Holmberg, Sara Bolin, Miao Zhao, Vasil Savov, Jessica M Rusert

Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.
Kristin L Leskoske, Krystine Garcia-Mansfield, Ritin Sharma, Aparna Krishnan, Jessica M Rusert

J Proteome Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures.
Michael Hu, Xin Yi Lei, Jon D Larson, Melissa McAlonis, Kyle Ford, Jessica M Rusert

Biomaterials· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.
Alexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, Lianne Q Chau, Meher Beigi Masihi, Jessica M Rusert

Nat Neurosci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.
Jessica M Rusert, Edwin F Juarez, Sebastian Brabetz, James Jensen, Alexandra Garancher

Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.
Alexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, Lianne Q Chau, Meher Beigi Masihi, Jessica M Rusert

Nat Neurosci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolving medulloblastoma cellular architecture by single-cell genomics.
Volker Hovestadt, Kyle S Smith, Laure Bihannic, Mariella G Filbin, McKenzie L Shaw, Jessica M Rusert

Nature· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
Varun V Prabhu, Neel S Madhukar, Coryandar Gilvary, C Leah B Kline, Sophie Oster, Jessica Rusert

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma.
Catherine Lee, Vasilisa A Rudneva, Serap Erkek, Marc Zapatka, Lianne Q Chau, Jessica M Rusert

Nat Commun· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Teresa Purzner, James Purzner, Taylor Buckstaff, Giorgio Cozza, Sharareh Gholamin, Jessica M Rusert

Sci Signal· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.
Kristen M Turner, Viraj Deshpande, Doruk Beyter, Tomoyuki Koga, Jessica Rusert

Nature· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling of high risk medulloblastoma reveals functional biology.
Jerome A Staal, Ling San Lau, Huizhen Zhang, Wendy J Ingram, Andrew R Hallahan, Jessica M Rusert

Oncotarget· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SnapShot: Medulloblastoma.
Jessica M Rusert, Xiaochong Wu, Charles G Eberhart, Michael D Taylor, Robert J Wechsler-Reya

Cancer Cell· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.
Daniel J Goff, Angela Court Recart, Anil Sadarangani, Hye-Jung Chun, Christian L Barrett, Jessica Rusert

Cell Stem Cell· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.
Qingfei Jiang, Leslie A Crews, Christian L Barrett, Hye-Jung Chun, Angela C Court, Jessica M Rusert

Proc Natl Acad Sci U S A· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis